Copyright Reports & Markets. All rights reserved.

Global and China Multiple Sclerosis Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Multiple Sclerosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Beta Interferon
    • 1.2.3 Corticosteroids
    • 1.2.4 Monoclonal Antibodies
    • 1.2.5 Antineoplastic Agents
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Multiple Sclerosis Therapeutics Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 e-Commerce
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Multiple Sclerosis Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Multiple Sclerosis Therapeutics Growth Trends by Regions
    • 2.2.1 Multiple Sclerosis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Multiple Sclerosis Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Multiple Sclerosis Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Multiple Sclerosis Therapeutics Players by Market Size
    • 3.1.1 Global Top Multiple Sclerosis Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Multiple Sclerosis Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Multiple Sclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Multiple Sclerosis Therapeutics Revenue
  • 3.4 Global Multiple Sclerosis Therapeutics Market Concentration Ratio
    • 3.4.1 Global Multiple Sclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Therapeutics Revenue in 2019
  • 3.5 Key Players Multiple Sclerosis Therapeutics Area Served
  • 3.6 Key Players Multiple Sclerosis Therapeutics Product Solution and Service
  • 3.7 Date of Enter into Multiple Sclerosis Therapeutics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple Sclerosis Therapeutics Breakdown Data by Type (2015-2026)

  • 4.1 Global Multiple Sclerosis Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Multiple Sclerosis Therapeutics Forecasted Market Size by Type (2021-2026)

5 Multiple Sclerosis Therapeutics Breakdown Data by Application (2015-2026)

  • 5.1 Global Multiple Sclerosis Therapeutics Historic Market Size by Application (2015-2020)
  • 5.2 Global Multiple Sclerosis Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Multiple Sclerosis Therapeutics Market Size (2015-2026)
  • 6.2 North America Multiple Sclerosis Therapeutics Market Size by Type (2015-2020)
  • 6.3 North America Multiple Sclerosis Therapeutics Market Size by Application (2015-2020)
  • 6.4 North America Multiple Sclerosis Therapeutics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Multiple Sclerosis Therapeutics Market Size (2015-2026)
  • 7.2 Europe Multiple Sclerosis Therapeutics Market Size by Type (2015-2020)
  • 7.3 Europe Multiple Sclerosis Therapeutics Market Size by Application (2015-2020)
  • 7.4 Europe Multiple Sclerosis Therapeutics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Multiple Sclerosis Therapeutics Market Size (2015-2026)
  • 8.2 China Multiple Sclerosis Therapeutics Market Size by Type (2015-2020)
  • 8.3 China Multiple Sclerosis Therapeutics Market Size by Application (2015-2020)
  • 8.4 China Multiple Sclerosis Therapeutics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Multiple Sclerosis Therapeutics Market Size (2015-2026)
  • 9.2 Japan Multiple Sclerosis Therapeutics Market Size by Type (2015-2020)
  • 9.3 Japan Multiple Sclerosis Therapeutics Market Size by Application (2015-2020)
  • 9.4 Japan Multiple Sclerosis Therapeutics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Multiple Sclerosis Therapeutics Market Size (2015-2026)
  • 10.2 Southeast Asia Multiple Sclerosis Therapeutics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Multiple Sclerosis Therapeutics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Multiple Sclerosis Therapeutics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Company Details
    • 11.1.2 Novartis Business Overview
    • 11.1.3 Novartis Multiple Sclerosis Therapeutics Introduction
    • 11.1.4 Novartis Revenue in Multiple Sclerosis Therapeutics Business (2015-2020))
    • 11.1.5 Novartis Recent Development
  • 11.2 Teva Pharmaceuticals
    • 11.2.1 Teva Pharmaceuticals Company Details
    • 11.2.2 Teva Pharmaceuticals Business Overview
    • 11.2.3 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Introduction
    • 11.2.4 Teva Pharmaceuticals Revenue in Multiple Sclerosis Therapeutics Business (2015-2020)
    • 11.2.5 Teva Pharmaceuticals Recent Development
  • 11.3 Sanofi Genzyme
    • 11.3.1 Sanofi Genzyme Company Details
    • 11.3.2 Sanofi Genzyme Business Overview
    • 11.3.3 Sanofi Genzyme Multiple Sclerosis Therapeutics Introduction
    • 11.3.4 Sanofi Genzyme Revenue in Multiple Sclerosis Therapeutics Business (2015-2020)
    • 11.3.5 Sanofi Genzyme Recent Development
  • 11.4 Bayer
    • 11.4.1 Bayer Company Details
    • 11.4.2 Bayer Business Overview
    • 11.4.3 Bayer Multiple Sclerosis Therapeutics Introduction
    • 11.4.4 Bayer Revenue in Multiple Sclerosis Therapeutics Business (2015-2020)
    • 11.4.5 Bayer Recent Development
  • 11.5 Pfizer
    • 11.5.1 Pfizer Company Details
    • 11.5.2 Pfizer Business Overview
    • 11.5.3 Pfizer Multiple Sclerosis Therapeutics Introduction
    • 11.5.4 Pfizer Revenue in Multiple Sclerosis Therapeutics Business (2015-2020)
    • 11.5.5 Pfizer Recent Development
  • 11.6 Biogen Idec
    • 11.6.1 Biogen Idec Company Details
    • 11.6.2 Biogen Idec Business Overview
    • 11.6.3 Biogen Idec Multiple Sclerosis Therapeutics Introduction
    • 11.6.4 Biogen Idec Revenue in Multiple Sclerosis Therapeutics Business (2015-2020)
    • 11.6.5 Biogen Idec Recent Development
  • 11.7 Merck
    • 11.7.1 Merck Company Details
    • 11.7.2 Merck Business Overview
    • 11.7.3 Merck Multiple Sclerosis Therapeutics Introduction
    • 11.7.4 Merck Revenue in Multiple Sclerosis Therapeutics Business (2015-2020)
    • 11.7.5 Merck Recent Development
  • 11.8 AbbVie
    • 11.8.1 AbbVie Company Details
    • 11.8.2 AbbVie Business Overview
    • 11.8.3 AbbVie Multiple Sclerosis Therapeutics Introduction
    • 11.8.4 AbbVie Revenue in Multiple Sclerosis Therapeutics Business (2015-2020)
    • 11.8.5 AbbVie Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Multiple Sclerosis Therapeutics Scope and Market Size
    Multiple Sclerosis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Sclerosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Beta Interferon
    Corticosteroids
    Monoclonal Antibodies
    Antineoplastic Agents
    Others

    Market segment by Application, split into
    Hospital Pharmacies
    Retail Pharmacies
    e-Commerce

    Based on regional and country-level analysis, the Multiple Sclerosis Therapeutics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Multiple Sclerosis Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Novartis
    Teva Pharmaceuticals
    Sanofi Genzyme
    Bayer
    Pfizer
    Biogen Idec
    Merck
    AbbVie

    Buy now